Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ENTX
#3424
Entera Bio Ltd. Ordinary Shares
1.3
9
-8.55%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-8.55%
Variazione Mensile
-11.46%
Variazione di 6 mesi
-30.15%
Variazione Annuale
-27.60%
Chiusura Precedente
1.5
2
Open
1.3
9
Bid
Ask
Low
1.3
9
High
1.3
9
Volume
2
Mercati
Mercato Azionario Statunitense
Salute
ENTX
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
36.83 M
45.42 M
45.45 M
45.66 M
45.86 M
—
Valuation ratios
Enterprise value
63.07 M
87.63 M
64.7 M
75.9 M
79.47 M
307.7 M
Price to earnings ratio
7.31
8.48
6.54
7.31
8
30.33
Price to sales ratio
716.31
440.99
293.17
445.81
610.26
1 790.23
Price to cash flow ratio
-8.12
-11.71
-10.33
-11.63
-12.05
-45.72
Price to book ratio
1.9
9.88
1.6
1.58
1.42
14.48
Enterprise value to EBITDA ratio
-6.65
-9.19
-6.44
-7.19
-7.37
-30.19
Profitability ratios
Return on assets %
0.39
0.25
0.12
0.14
0.18
0.69
Return on equity %
0.47
0.29
0.13
0.15
0.21
0.79
Return on invested capital %
2 062.87
1 614.6
—
—
—
—
Gross margin %
0
0
0
—
—
—
Operating margin %
7 109.52
2 832.93
6 102.38
—
—
—
EBITDA margin %
-7 166.67
-2 836.59
-6 083.33
—
—
—
Net margin %
7 192.86
2 875.61
6 111.9
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
6.61
7.63
13.07
10.47
10.83
42
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0.01
0
0
0
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
0.02
0.03
0.03
—
Long term debt to total equity ratio
—
—
0.03
0.03
0.03
—
Per share metrics
Operating cash flow per share
0.06
0.04
0.03
0.04
0.05
0.16
EBIT per share
-0.08
-0.06
-0.06
-0.06
-0.07
-0.25
EBITDA per share
-0.08
-0.06
-0.06
-0.06
-0.07
-0.25
Total debt per share
—
—
—
—
—
—
Cash per share
0.19
0.23
0.29
0.24
0.19
0.95
Net current asset value per share
0.2
0.24
0.49
0.43
0.37
1.53
Tangible book value per share
0.17
0.21
0.45
0.38
0.33
1.38
Working capital per share
0.17
0.21
0.45
0.39
0.34
1.38
Book value per share
0.17
0.21
0.45
0.38
0.33
1.38
Notizie
What Pushed Entera Bio (ENTX) To Rally Nearly 16% After Hours - Entera Bio (NASDAQ:ENTX)
H.C. Wainwright reitera calificación de Compra para acciones de Opko Health
Opko Health stock rating reiterated at Buy by H.C. Wainwright
Entera Bio nombra a Geno Germano como presidente de la junta directiva
Entera Bio appoints Geno Germano as board chairman
OPKO y Entera amplían colaboración para desarrollar tratamiento oral de PTH
OPKO and Entera expand collaboration to develop oral PTH treatment
Entera Bio planea presentar su medicamento para osteoporosis a la FDA en el primer trimestre de 2026
Entera Bio planea presentar solicitud a la FDA para fármaco de osteoporosis en 1T 2026
Entera Bio plans FDA submission for osteoporosis drug in Q1 2026
H.C. Wainwright mantiene recomendación de Compra para Entera Bio tras validación de FDA
H.C. Wainwright mantiene calificación de Compra para Entera Bio tras validación de la FDA